Skip to content
Precision for Medicine
Press Release

FDA Veteran Paz Vellanki, MD, joins Precision to become one of 3 ex-FDA oncology leaders supporting clients

news-feed-banner

News Feed

Articles, industry coverage and commentary

All news

  • Alliance for Regenerative Medicine's Action for Equality Task Force Initiatives

    Discover
  • Mark Clein, Co-Founder and CEO of Precision Medicine Group, delivers the keynote address for BioTrinity 2020

    Discover
  • Precision for Medicine Partners with Karyopharm Therapeutics to Initiate New Global Clinical Trial to Treat Patients with COVID-19

    Discover
  • How Precision is responding to COVID-19

    Discover
  • EVICTION Trial to Evaluate Anti-cancer Drug ICT01 Launches

    Discover